Literature DB >> 2858122

Prostaglandin E2 receptors on human peripheral blood monocytes.

E F Eriksen, B Richelsen, H Beck-Nielsen, F Melsen, H K Nielsen, L Mosekilde.   

Abstract

The prostaglandin E2 (PGE2) receptor on human peripheral blood monocytes is characterized. The receptor binding at physiological temperature and pH was saturable, specific, and reversible. Scatchard analysis of binding data revealed a linear plot giving a Kd = 1.1 X 10(-9) mol/l and Bmax = 4.1 fmol/10(7) cells, equal to 240 binding sites per cell. PGE2 increased intracellular cyclic adenosine 5'-monophosphate by a maximal factor of 3. PGF2 alpha and arachidonic acid had no stimulatory effects on adenyl cyclase, in accordance with their low binding to the cells. The characterization of the PGE2 receptor on human monocytes creates a basis for the study of the clinical significance of changes in PGE2-receptor binding in disease states involving PGE2-monocyte interactions such as various immunological disorders and bone resorption.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858122     DOI: 10.1111/j.1365-3083.1985.tb01416.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.

Authors:  W Awara; K Hillier; D Jones
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

2.  An EP receptor with a novel pharmacological profile in the T-cell line Jurkat.

Authors:  G W De Vries; P Guarino; A McLaughlin; J Chen; S Andrews; D F Woodward
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

3.  A study on plasma prostaglandin E2 levels in hepatitis B carriers and patients with chronic active hepatitis.

Authors:  J H Kim; Y S Heo; K Y Ahn; Y G Lee; D G Kim; D S Ahn
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.